EUVIMEDEUVIMED entdecken
Crossref

5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation

Maosheng Yang, Zhiyuan Yu, Hanbin Wang, Yitong Geng, Rongrong Li, Jinqiao Qiao, Yi Li

Bone · 2026-09 · 210 · 117935

DOI: 10.1016/j.bone.2026.117935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026-09. Verfasst von Maosheng Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery and Sports Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Osteoporosis, Signal Transduction. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Shandong Province Department of Science and Technology, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesOsteoporosisSignal TransductionOsteogenesisNetwork PharmacologyCoumarinsUmbelliferonesAnimalsFemaleOsteoclastsMolecular Docking SimulationMiceBone ResorptionOvariectomyMice, Inbred C57BLMolecular Dynamics Simulation

Stichwörter der Autor:innen

5,7-DihydroxycoumarinMolecular dockingNetwork pharmacologyOsteoclastOsteoporosisOvariectomyPI3K/Akt

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCoumarinsUmbelliferones

Autor:innen und Institutionen

  • Department of Joint Surgery and Sports Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Department of Joint Surgery and Sports Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Electronic address: liyivinvent-@outlook.com.

Förderung

  • Shandong Province Department of Science and Technology
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Yang, M., Yu, Z., Wang, H., Geng, Y., Li, R., Qiao, J., & Li, Y. (2026). 5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation. Bone, 210, 117935. https://doi.org/10.1016/j.bone.2026.117935

Vancouver

Yang M, Yu Z, Wang H, Geng Y, Li R, Qiao J, et al. 5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation. Bone. 2026;210:117935. doi:10.1016/j.bone.2026.117935

BibTeX
@article{Yang2026,
  author = {Yang, Maosheng and Yu, Zhiyuan and Wang, Hanbin and Geng, Yitong and Li, Rongrong and Qiao, Jinqiao and Li, Yi},
  title = {5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation},
  journal = {Bone},
  year = {2026},
  volume = {210},
  pages = {117935},
  doi = {10.1016/j.bone.2026.117935}
}
Kostenlos starten →